Biomarker
IL-6 (Interleukin-6)
Last updated Sun May 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
What it is
IL-6 is a pleiotropic cytokine produced by immune cells, adipocytes, muscle cells (during exercise), and senescent cells. It drives the acute- phase response (including hsCRP production by the liver) and modulates immune cell differentiation.
Why it matters
Persistent elevation of IL-6 is one of the most consistent age-related biomarker changes (“inflammaging”). Elevated IL-6 predicts:
- Cardiovascular events.
- Frailty and sarcopenia.
- Cancer incidence in some sites.
- Cognitive decline.
- All-cause mortality.
The exercise paradox
Acutely during exercise, IL-6 from contracting muscle (“myokine IL-6”) has anti-inflammatory and metabolic-signalling roles — opposite to the chronic, low-grade IL-6 produced by adipose tissue and senescent cells. Same molecule, different context.
What lowers chronic IL-6
- Weight loss (especially visceral fat).
- Exercise (training adaptation reduces baseline IL-6).
- Mediterranean diet and omega-3 intake.
- Smoking cessation.
- Pharmacology: statins, GLP-1 agonists, colchicine, IL-6 receptor blockade (tocilizumab, sarilumab) in autoimmune disease.
Related entries
References
- Maggio, M. et al. Interleukin-6 in aging and chronic disease. J. Gerontol. A 61, 575–584 (2006).